Clinical trial
Phase 2/3 Evaluation of Three Lactobacilli Strains Isolated From Human Milk for the Treatment of Infectious Mastitis During the Lactation Period
NCT00716183 is registered in ClinicalTrials.gov with Universidad Complutense de Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2/3 Evaluation of Three Lactobacilli Strains Isolated From Human Milk for the Treatment of Infectious Mastitis During the Lactation Period
- Lead sponsor
- Universidad Complutense de Madrid
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- May 31, 2009
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.